Drug Trial Radar · NCT06520826
Vafseo Outcomes In-Center Experience
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,116
Actual
Start
Nov 20, 2024
Primary completion
Sep 10, 2026
Study completion Nov 5, 2026
Sponsor
- Lead sponsor
- USRC Kidney ResearchResearch network
- Sponsor type
- Research network
- Collaborators
- Akebia Therapeutics
- First posted
- Jul 25, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment of anemia in in-center hemodialysis patients with End Stage Kidney Disease (ESKD). This study will obtain long-term safety data in a large sample of subjects receiving in-center hemodialysis to support adoption of three times per week vadadustat dosing.
Conditions
- Anemia of Chronic Kidney Disease
Interventions
VadadustatDrug
A synthetic, orally bioavailable, small molecule being developed as an inhibitor of hypoxia-inducible factor prolyl-hydroxylases for the treatment of anemia associated with chronic kidney disease. Intervention to be administered to maintain hemoglobin within a target range of 10-11 g/dL.
Erythropoiesis Stimulating AgentDrug
Standard of care erythropoiesis stimulating agent will be administered to maintain hemoglobin within a target range of 10-11 g/dL.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Combination of the hierarchical endpoints of all-cause mortality and all-cause hospitalization.Time frame: 18 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
USRC Kidney Research
Lone Tree, Colorado
Nephrology and Hypertension Specialists, PC
Dalton, Georgia
US Renal Care - Gallup
Gallup, New Mexico
Dallas Renal Group
Dallas, Texas
US Renal Care - Live Oak
Live Oak, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.